Brian Armstrong

Who they are

Brian Armstrong is Co-Founder and CEO of Coinbase — started UniversityTutor.com in 2003 as a student and co-founded NewLimit, a longevity biotech startup targeting age-reversing therapies via epigenetic reprogramming.

Person

Brian Armstrong co-founded Coinbase in June 2012 when it was a seed-stage startup in Y Combinator's 2012 batch with a $150K YC investment and a $619K seed round — he has run it ever since, through IPO and into its current position as the largest cryptocurrency exchange in the United States. He graduated from Rice University in 2006 with a B.S. and M.S. in Computer Science and a B.A. in Economics, then worked as a software engineer at Airbnb before going full founder. The earliest signal of his builder instinct is UniversityTutor.com, an online tutoring marketplace he started in 2003 while still a student. He has co-founded five distinct ventures beyond Coinbase: UniversityTutor.com; Coinbase itself (with Fred Ehrsam); ResearchHub, a scientific collaboration platform; GiveCrypto.org, a crypto-based charitable giving fund (he has also signed the Giving Pledge); and NewLimit, a longevity biotech startup co-founded in 2021 with Blake Byers and Jacob Kimmel, focused on age-reversing therapies using AI and epigenetics. The through-line is using technology to rewire existing systems — financial rails, scientific publishing, and now human biology. He writes at brianarmstrong.org on crypto adoption, regulation, longevity research, and founder psychology, and shows up regularly on Bloomberg Talks, Tim Ferriss, Conversations with Tyler, and Honestly with Bari Weiss.

Company

Coinbase's most recent financial update — Q1 2026 results — showed resilient performance with record derivatives trading revenue and stablecoin transaction volume leadership. The biggest strategic move in recent history was the $2.9B acquisition of Deribit, completed May 8, 2025, which expanded Coinbase's global crypto derivatives reach significantly. In 2025 Coinbase doubled total trading volume and crypto trading volume market share, and reached approximately 1 million Coinbase One subscriptions. The product roadmap is now pointed at becoming an 'everything exchange' in 2026, integrating crypto, equities, prediction markets, and commodities on a single platform, alongside AI-powered tools and a stablecoin payment standard called x402 that enables AI agents to transact using stablecoins.

Market

Coinbase holds entrenched leadership in U.S. crypto exchange infrastructure, with a market capitalization of $66 billion as of December 2025 and $7.18B in annual revenue as of that same period. Its main rivals are Binance (dominant in global retail volume), Kraken (strong in the U.S. and EU with a compliance-first positioning), and Bitget (gaining traction as a cost-effective high-volume option). The regulatory environment shifted materially in 2025: the SEC dismissed its landmark case against Coinbase in February 2025, FIT21 passed providing clear rules Coinbase had long lobbied for, and spot Bitcoin and Ethereum ETFs approved in late 2024 repositioned Coinbase as the primary custodian for the traditional financial establishment — while its USDC stablecoin has become a strategic asset in 'digital dollar' initiatives.

Network

Armstrong's closest named collaborators span two worlds: Fred Ehrsam, his Coinbase co-founder, is the longest-standing professional relationship. On the NewLimit side, Blake Byers and Jacob Kimmel are co-founders working alongside him on longevity biotech. Ben Horowitz of Andreessen Horowitz has been a visible investor and podcast interlocutor, reflecting a16z's deep involvement in the Coinbase story.

Fred Ehrsam· Co-founder, Coinbase
Blake Byers· Co-founder, NewLimit
Jacob Kimmel· Co-founder, NewLimit
Ben Horowitz· General Partner, Andreessen Horowitz

How they likely show up

Long tenure as Coinbase CEO from seed stage through IPO and beyond (joined June 2012) → thinks in decade-long arcs; unlikely to be impressed by short-term tactical framing.
Five co-founded companies across crypto, science, charity, and biotech — all running simultaneously → extremely high agency, pursues parallel bets rather than sequential ones.
Tim Ferriss Show episode titled 'The Art of Relentless Focus' → self-identifies as someone who has had to fight distraction and build systems for prioritization; focus is a stated value, not a given.
Active public writer at brianarmstrong.org covering crypto regulation, longevity, and founder psychology → comfortable owning a point of view and putting it in writing; probably expects counterparts to have done their reading.
Signed the Giving Pledge and founded GiveCrypto.org → philanthropy is not a PR afterthought but a structured commitment; mission-language will resonate if it's substantive.
Dual B.S./M.S. in Computer Science plus B.A. in Economics from Rice → brings both engineering precision and economic systems-thinking to product and policy arguments.

Conversation tips

→ Reference a specific essay from brianarmstrong.org or a Bloomberg Talks appearance — he'll know immediately whether you've read anything or are winging it.
→ Lead with the derivatives or stablecoin angle if relevant — the Deribit acquisition and x402 payment standard are clearly where his strategic attention is right now.
→ Frame ideas in terms of systemic change, not incremental improvement — his track record (Coinbase, NewLimit, ResearchHub) shows he bets on rewiring entire systems.
→ Don't conflate NewLimit with Coinbase as topics — he keeps them distinct, and mixing them signals you haven't thought carefully about which conversation you're in.
→ Bring a concrete position, not a question about his journey — he's been asked the origin story many times; a sharp take on crypto regulation or longevity science will get more traction.

Toolbox

Openers

Open on x402 — Coinbase's new stablecoin payment standard letting AI agents transact directly; it's a pointed infrastructure bet that only makes sense if you believe stablecoins become the default payment rail, and it's a live product decision right now.
Ask about NewLimit's $130M raise — he co-founded a longevity biotech focused on epigenetic reprogramming alongside running Coinbase, and the framing (age-reversing medicines via AI) is the kind of parallel conviction bet worth understanding on its own terms.
Reference the Deribit acquisition specifically — paying $2.9B to enter global crypto derivatives in May 2025 is the biggest capital allocation decision he's made since the IPO, and his reasoning for it will reveal how he thinks about Coinbase's international competitive position.

Discovery questions

The 'everything exchange' roadmap — crypto, equities, prediction markets, commodities on one platform — is a significant scope expansion. What's the sequencing logic, and where does regulatory risk sit for each asset class?
You've expanded tradable assets from 300 to over 40,000 in the U.S. through DEX protocol integration. How do you think about curation versus breadth when trust and compliance are core to the Coinbase brand?
NewLimit is working on epigenetic reprogramming while you're running a public company at scale. How do you structure your attention across them, and what would cause you to shift more time toward NewLimit?

Avoid

Don't open with generic crypto-is-the-future boosterism — Armstrong has spent over a decade building the infrastructure case in precise regulatory and product terms, and vague enthusiasm signals you haven't engaged with the specifics.

Make it yours